FULGENT GENETICS, INC. Taxes Payable, Current
FULGENT GENETICS, INC. (FLGT) had Taxes Payable, Current of $426.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2023-02-28
- 2022-09-30: Taxes Payable, Current $426.00K.
- 2022-06-30: Taxes Payable, Current $2.80M.
- 2022-03-31: Taxes Payable, Current $52.16M.
- 2021-12-31: Taxes Payable, Current $787.00K.
| Period end | Taxes Payable, Current |
|---|---|
| 2022-09-30 | $426.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $2.80M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $52.16M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $787.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $17.88M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $26.40M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $120.52M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $53.32M 10-K · filed 2022-02-28 |
| 2020-09-30 | $14.63M 10-Q · filed 2020-11-09 |
| 2020-03-31 | $56.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $24.00K 10-K · filed 2021-03-08 |
| 2019-09-30 | $60.00K 10-Q · filed 2019-11-08 |
| 2017-03-31 | $230.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $124.00K 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |